Jose Spring gives us a brief overview of her work investigating therapeutic gardening for patients with neurodisability and dementia in both the UK and Scandinavia.
Browsing: Cognitive/neurodegenerative disorders
A new study has indicated that high levels of TREM2 within monocytes are linked to an increased risk of Alzheimer’s disease. The study results help to further unravel the role of the immune system within the disease.
The use of dopamine agonists for Parkinson’s treatment is often associated with unwanted side effects. This review identifies strategies for managing or avoiding these effects and discusses future needs to improve the understanding of these phenomena.
This article investigates the neuroprotective potential of systemic CD34+ human cord blood cells (hCBCs) in a 6-hydroxydopamine rat model of Parkinson’s disease.
A newly developed light-sensitive plant–human hybrid protein may effectively modulate Ca2+ channel regulation, bolstering memory formation in mice.
The 2015 Rugby World Cup has sparked discussions over the control of and education around head injuries within both rugby and other sports. We highlight some of the key focuses of the debate and key recent research articles from the journal Concussion.
This review article evaluates best practice standards for selecting patient-reported outcome measures in neurodegenerative conditions.
This article looks at the impacts of the inclusion of family members in the care delivery and decision-making of hospitalized persons with dementia.
A newly identified ‘early warning’ gene signature may help to predict the onset of Alzheimer’s disease.
Genetic variants identified within a cohort of subjects with Alzheimer’s disease have been associated with a delay in age of onset of up to 10 years.